John J. Chandler
Corporate Officer/Principal presso Licensing Executives Society
Posizioni attive di John J. Chandler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Licensing Executives Society | Corporate Officer/Principal | - | - |
Storia della carriera di John J. Chandler
Precedenti posizioni note di John J. Chandler
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Apex Bioventures Acquisition Corp.
 Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Direttore/Membro del Consiglio | 01/06/2006 | 04/06/2009 |
Cellegy Pharmaceuticals, Inc.
 Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cellegy Pharmaceuticals specialty biopharmaceutical company, that is primarily engaged in the development and commercialization of prescription drugs targeting women’s health care, including reduction in transmission of HIV and female sexual dysfunction, and gastrointestinal conditions using proprietary topical formulations and nitric oxide, or NO, donor technologies | Corporate Officer/Principal | 01/05/1999 | 01/09/2006 |
| Sherwood Davis & Geck | Corporate Officer/Principal | 01/01/1995 | 01/05/1998 |
| Cyanamid International Corp. | Corporate Officer/Principal | 01/08/1968 | 01/12/1994 |
| Lederle International | Corporate Officer/Principal | - | - |
Formazione di John J. Chandler
| Seton Hall University | Masters Business Admin |
| City University of New York | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 9 |
Posizioni
| Corporate Officer/Principal | 5 |
| Masters Business Admin | 1 |
| Undergraduate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 6 |
|---|---|
Cellegy Pharmaceuticals, Inc.
Cellegy Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cellegy Pharmaceuticals specialty biopharmaceutical company, that is primarily engaged in the development and commercialization of prescription drugs targeting women’s health care, including reduction in transmission of HIV and female sexual dysfunction, and gastrointestinal conditions using proprietary topical formulations and nitric oxide, or NO, donor technologies | Health Technology |
Apex Bioventures Acquisition Corp.
Apex Bioventures Acquisition Corp. Financial ConglomeratesFinance The Company is a blank check company. It is formed to acquire one or more domestic or foreign operating business in the healthcare industry through merger, capital stock exchange, asset acquisition or other similar business combination. The Company is in the development stage. On February 5, 2008, the Company entered into an Agreement and Plan of Merger with Dynogen Pharmaceuticals, Inc and its acting representatives. | Finance |
| Sherwood Davis & Geck | Health Technology |
| Cyanamid International Corp. | |
| Licensing Executives Society | |
| Lederle International |
- Borsa valori
- Insiders
- John J. Chandler
- Esperienza
